MedTrace Logo

Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias

NCT07224139 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 13435

Last updated 2025-11-04

No results posted yet for this study

Summary

Blood-based ADRD biomarkers show tremendous promise as a non-invasive method to predict and diagnose ADRD. We will measure changes in these biomarkers to determine whether their ability to predict ADRD differs by sex or by other characteristics, and develop a sex-specific ADRD risk score for personalized medicine and clinical trials.

Conditions

  • Alzheimer Disease
  • Dementia
  • Cognitive Dysfunction

Sponsors & Collaborators

  • Anne Murray

    lead OTHER

Principal Investigators

  • Anne Murray, MD, MSc · Hennepin Healthcare Research Institute

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07224139 on ClinicalTrials.gov